Ben Zichri-David S, Shkuri L, Ast T
NPJ Metab Health Dis. 2025; 3(1):6.
PMID: 40052109
PMC: 11879881.
DOI: 10.1038/s44324-024-00045-y.
Khan M
Biomolecules. 2025; 15(2).
PMID: 40001517
PMC: 11853559.
DOI: 10.3390/biom15020214.
Ferretti S, Zanella I
Int J Mol Sci. 2024; 25(23).
PMID: 39684697
PMC: 11640923.
DOI: 10.3390/ijms252312987.
Zhang F, Ye Z, Xie Y, Liu M, Zhang L, Zhang J
Biometals. 2024; 37(6):1307-1323.
PMID: 39212870
DOI: 10.1007/s10534-024-00628-8.
Lee S, Kovacs G
Int J Mol Sci. 2024; 25(8).
PMID: 38673855
PMC: 11049980.
DOI: 10.3390/ijms25084269.
Mapping the Research of Ferroptosis in Parkinson's Disease from 2013 to 2023: A Scientometric Review.
Chen Y, Wu Z, Li S, Chen Q, Wang L, Qi X
Drug Des Devel Ther. 2024; 18:1053-1081.
PMID: 38585257
PMC: 10999190.
DOI: 10.2147/DDDT.S458026.
Iron Deposition in Parkinson's Disease: A Mini-Review.
Zeng W, Cai J, Zhang L, Peng Q
Cell Mol Neurobiol. 2024; 44(1):26.
PMID: 38393383
PMC: 10891198.
DOI: 10.1007/s10571-024-01459-4.
Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera.
Tong Y, Zhang P, Yang X, Liu X, Zhang J, Grudniewska M
Proc Natl Acad Sci U S A. 2024; 121(2):e2306682120.
PMID: 38181056
PMC: 10786272.
DOI: 10.1073/pnas.2306682120.
Brain Iron Metabolism, Redox Balance and Neurological Diseases.
Gao G, You L, Zhang J, Chang Y, Yu P
Antioxidants (Basel). 2023; 12(6).
PMID: 37372019
PMC: 10294882.
DOI: 10.3390/antiox12061289.
Secondary structures in RNA synthesis, splicing and translation.
Georgakopoulos-Soares I, Parada G, Hemberg M
Comput Struct Biotechnol J. 2022; 20:2871-2884.
PMID: 35765654
PMC: 9198270.
DOI: 10.1016/j.csbj.2022.05.041.
Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease.
Boag M, Roberts A, Uversky V, Ma L, Richardson D, Pountney D
Int J Mol Sci. 2022; 23(4).
PMID: 35216492
PMC: 8878351.
DOI: 10.3390/ijms23042378.
The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention.
Boas S, Joyce K, Cowell R
Antioxidants (Basel). 2022; 11(1).
PMID: 35052512
PMC: 8772787.
DOI: 10.3390/antiox11010008.
Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis.
Kazemi Shariat Panahi H, Dehhaghi M, Heng B, Lane D, Bush A, Guillemin G
Neurotox Res. 2022; 40(2):614-635.
PMID: 35023054
DOI: 10.1007/s12640-021-00455-6.
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy.
Finkelstein D, Shukla J, Cherny R, Billings J, Saleh E, Stefanova N
J Parkinsons Dis. 2021; 12(1):105-115.
PMID: 34744051
PMC: 9028676.
DOI: 10.3233/JPD-212877.
Alpha-synuclein increases in rodent and human spinal cord injury and promotes inflammation and tissue loss.
Sauerbeck A, Goldstein E, Alfredo A, Norenberg M, Marcillo A, McTigue D
Sci Rep. 2021; 11(1):11720.
PMID: 34083630
PMC: 8175699.
DOI: 10.1038/s41598-021-91116-3.
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies.
Ma L, Azad M, Dharmasivam M, Richardson V, Quinn R, Feng Y
Redox Biol. 2021; 41:101896.
PMID: 33799121
PMC: 8044696.
DOI: 10.1016/j.redox.2021.101896.
Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules.
Cahill C, Aleyadeh R, Gao J, Wang C, Rogers J
Biomolecules. 2020; 10(10).
PMID: 33096655
PMC: 7589448.
DOI: 10.3390/biom10101465.
Small molecule recognition of disease-relevant RNA structures.
Meyer S, Williams C, Akahori Y, Tanaka T, Aikawa H, Tong Y
Chem Soc Rev. 2020; 49(19):7167-7199.
PMID: 32975549
PMC: 7717589.
DOI: 10.1039/d0cs00560f.
Iron-responsive-like elements and neurodegenerative ferroptosis.
Rogers J, Cahill C
Learn Mem. 2020; 27(9):395-413.
PMID: 32817306
PMC: 7433652.
DOI: 10.1101/lm.052282.120.
Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway.
Shi L, Huang C, Luo Q, Xia Y, Liu W, Zeng W
Aging (Albany NY). 2020; 12(10):9515-9533.
PMID: 32424108
PMC: 7288933.
DOI: 10.18632/aging.103225.
